“All they have to do is go into the Open Payments database. I mean, how hard is that?” — Barbara Redman, PhD, MBE, of New York University School of Medicine’s Grossman division of medical ethics, on authors disclosing conflicts of interest.
“We need to do more.” — Debra Houry, MD, MPH, CDC chief medical officer, on reducing gaps in vaccination coverage for children in the Vaccines For Children program.
“The costs are just tremendous.” — Lori Smetanka, of the National Consumer Voice for Quality Long-Term Care in Washington, D.C., on rising healthcare costs for older adults.
“Avoid handing children mobile devices as a strategy for calming them, or as digital pacifiers.” — Caroline Fitzpatrick, PhD, of the Université de Sherbrooke in Canada, discussing the link between preschoolers’ tablet time and anger outbursts.
“This is fantastic, as there has always been this question as to whether the combination was safe in pregnancy.” — Gail D’Onofrio, MD, of the Yale School of Public Health in Connecticut, on treatments for pregnant women with opioid use disorder.
“It will be a point of pride if he could get better deals than they get.” — Former HHS Secretary Alex Azar, predicting potential changes in healthcare if there is a second Trump administration.
“Anywhere in the country … we can make this happen.” — Shane Jerominski, PharmD, co-founder of the Pharmacy Guild, after the first set of Walgreens employees filed to join the national union.
“The driving principle behind the work we’re doing is to assure affordability and ensure access.” — Stacy Sanders, HHS Chief Competition Officer, discussing 10 drugs with newly negotiated prices under Medicare.
Please enable JavaScript to view the